table of contents 
To directly radiolabel an anti-hepatoma mAb fragment HAb18 F(ab’)2 with 99mTc …
');
|
Biology Articles » Biophysics » Medical Biophysics » Direct technetium-99m labeling of anti-hepatoma monoclonal antibody fragment: a radioimmunoconjugate for hepatocellular carcinoma imaging » References
References - Direct technetium-99m labeling of anti-hepatoma monoclonal antibody fragment: a radioimmunoconjugate for hepatocellular carcinoma imaging
1 Rhodes BA.Direct
labeling of proteins with 99mTc.Nucl Med Biol,1991;18:667-676
2 Childs RL, Hnatowich DJ. Optimum condition for
labeling of DTPA coupled antibodies with Technetium-99m.
J
Nucl Med, 1985;26:293-299
3 Ultee ME, Bridger GJ, Abrams MJ, Longley CB,
Burton CA, Larsen SK, Henson GW, Padmanabhan S, Gaul FE,
Schwartz
DA.Tumor imaging with technetium-99m-labeled
hydrazinonicotinamide-Fab’ conjugates.J Nucl Med,1997;38:133-138
4 Joiris E, Bastin B, Thornback JR. A new method
for labeling of monoclonal antibodies and their fragments with
technetium-99m.Nucl Med
Biol,1991;18:353-356
5 Eckelman WC, Meinken G, Richards P. 99mTc-human
serum albumin. J Nucl Med, 1971;12:707-710
6 John E, Thakur ML, Wilder S, Alauddin MM,
Epstein AL. Technetium-99m-labeled monoclonal antibodies: influence
of
technetium-99m binding sites.J Nucl Med,
1994;35:876-881
7 Mather SJ, Ellison D. Reduction-mediated
technetium-99m labeling of monoclonal antibodies.J Nucl Med,
1990;31:692-697
8 Rhodes BA, Zamora PO, Newell KD, Valdez EF.
Technetium-99m labeling of murine monoclonal antibody fragments.
J Nucl Med, 1986;27:685-693
9 Pauwels EKJ, Welling MM, Feitsma RIJ, Atsma DE,
Nieuwenhuizen W. The labeling of proteins and LDL with 99mTc:
a newdirect
method employing KBH4 and stannous chloride. Nucl Med Biol,
1993;20:825-833
10 Schwarz SW, Connett JM, Anderson CJ, Rocque PA, Philpott GW,
Guo LW, Welch MJ. Evaluation of a direct method for
technetium labeling intact and F(ab’)2
lA3, an anticolorectal monoclonal antibody.Nucl Med Biol,
1994;21:619-626
11 Qi P, Muddukrishna SN, Both RT, Rahn J, Chen A. Direct
99mTc-labeling of antibodies by sodium dithionite reduction,
and role of ascorbate as a stabilizer in
cysteine challenge. Nucl Med Biol, 1996;23:827-835
12 Hnatowich DJ, Virzi F, Fogarasi M, Rusckowski M, Winnard-JR
P. Can a cysteine challenge assay predict the in vivo
behaviorof
99mTc-labeled antibodies. Nucl Med Biol, 1994;21:1035-1044
13 Sykes TR, Woo TK, Baum RP, Qi P, Noujaim AA. Direct
labeling of monoclonal antibodies with technetium 99m by
photoactivation.J Nucl Med,
1995;36:1913-1922
14 Nakayama M, Wada M, Araki N, Ginoza Y, Terahara T, Harada
K, Sugh A, Tomiguchi S,Kojima A, Hara M, Takahashi M.
Direct 99mTc labeling of human
immunoglobulin with an insoluble macromolecular Sn (Ⅱ)
complex.
Nucl Med Biol, 1995;22:795-802
15 Rosenzweig HS, Ranadive GN, Seskey T, Epperly MW, Bloomer
WD. A novel method for the non-chromatographic
purificationof technetium-99m-labeled monoclonal antibodies:a study with
B72.3 monoclonal antibody. Nucl Med
Biol,1994;21:171-178
16 Alauddin MM, Khawli LA, Epstein AL. An improved method of
direct labeling monoclonal antibodies with 99mTc.
Nucl Med Biol, 1992;19:445-454
17 Gooden CSR, Snook DE, Maraveyas A, Rowlinson BG, Peters AM,
Epenetos AA. Direct technetium 99m labeling of three
anticancer monoclonal antibodies:
stability, pharmacokinetics and imaging.J Nucl Med, 1995;36:842-849
18 Chen ZN, Liu YF, Yang JZ. Anti human hepatocellular
carcinoma monoclonal antibody and immunohistochemical location
of associated antigen P60.Dankelong Kangti
Tongxun, 1989;2:33-36
19 Qiu K, Chen ZN, Liu ZG, Wang Q, He FC, Qu P, Mi L, Sui YF,
Liu YF. Preparation of anti hepatoma McAb HAb18 F(ab’)2
and Fab fragments by papainic digestions
in different conditions.Disi Junyi Daxue Xuebao, 1995;16:414-417
20 Ellman GL. Tissue sulphydryl groups.Arch Bioch Biophys,
1959;82:70-77
21 Thrall JH, Freitas JE, Swanson D, Rogers WL, Clare JM,
Brown ML, Pitt B. Clinical comparison of cardiac blood pool
visualization with technetium-99m red
blood cells labeled in vivo and with technetium-99m human serum
albumin.
J Nucl Med, 1978;19:796-803
22 Lindmo T, Boven E, Cuttitta F, Fedorko J, Bunn-Jr PA.
Determination of the immunoreactive fraction of radiolabeled
monoclonal antibodies by linear
extrapolation to binding at infinite antigen excess.J Immun Med,
1984;72:77-89
23 Morrison RT, Lyster DM, Alcorn L, Rhodes BA, Breslow K,
Burchiel SW. Radioimmunoimaging with 99mTc monoclonal
antibodies: clinical studies. Int J Nucl
Med Biol, 1984;11:184-188
24 Bian HJ, Chen ZN, Deng JL, Duan XD, Mi L, Yu XL, Xu LQ.
Direct labeling of anti hepatoma monoclonal antibody fragment
with 99mTc by an improved pretinning
method. Tongweisu, 1999;12:90-94
25 Granowska M, Mather SJ, Britton KE, Bentley S, Richman P,
Phillips RKS, Northover JMA. 99mTc
radioimmunoscintigraphyof colorectal cancer. Br J Cancer, 1990;62(Suppl Ⅹ):30-33
26 Hnatowich DJ, Mardirossian G, Rusckowski M, Fogarasi M,
Virzi F, Winnard-Jr P. Directly and indirectly technetium-
99m-labeled
antibodies-a comparison of in vitro and animal in vivo properties. J
Nucl Med, 1993;34:109-119
27 Behr TM, Becker WS, Sharkey RM, Juweid ME, Dunn RM, Bair HJ,
Wolf FG, Goldenberg DM. Reduction of renal uptake
ofmonoclonal antibody fragments by amino
acid infusion. J Nucl Med, 1996;37:829-833
rating: 0.00 from 0 votes | updated on: 28 Nov 2008 | views: 4224 |
|
Answers to all your Biology Questions
